Back to stories
Industry

Roundhill's DRAM ETF Hits $6.5B in 36 Days as Memory Becomes AI's Bottleneck

Michael Ouroumis2 min read
Roundhill's DRAM ETF Hits $6.5B in 36 Days as Memory Becomes AI's Bottleneck

The Roundhill Memory ETF (DRAM) crossed $6.5 billion in assets under management within 36 trading days of its April 2, 2026 launch — the fastest ETF on record to reach that milestone. The fund had crossed $1 billion after 10 trading days and $5 billion after 25, and has roughly doubled in price since launch, with reported 2026 gains tracking near 100%.

The vehicle is a pure-play bet on the thesis that memory, not GPUs, is now the binding constraint on AI infrastructure expansion.

Memory as the New Choke Point

"Investors are waking up to the fact that the biggest bottleneck in the AI build-out is actually memory chips," Roundhill CEO Dave Mazza told CNBC on May 15. He added: "Memory has been identified as the clear AI bottleneck, and there is a shortage of these chips that is going to last not for a quarter but multiple years."

The argument has been gaining traction across hyperscaler earnings. Microsoft's recent capex revision to $190 billion for 2026 attributed roughly $25 billion of the increase to memory and component price inflation. High-bandwidth memory used in Nvidia and AMD accelerators has been the sharpest mover, with HBM stacks reportedly sold out across vendors well into next year.

The Three-Vendor Lock

DRAM's portfolio reflects how concentrated the supply side has become. As of May 8, 2026, the top three holdings were approximately Samsung at 25%, SK hynix at 24%, and Micron at 24% — collectively about three-quarters of the fund. Those same three names control essentially all HBM3E and HBM4 production capacity scheduled to ship into AI accelerator platforms through 2027. (Weightings fluctuate daily; see Roundhill's official holdings page for current values.)

That concentration is what makes the trade structurally different from a broad semiconductor index. Where logic foundry capacity has multiple expansion paths (TSMC, Intel, Samsung Foundry, emerging Chinese fabs), HBM is a three-player oligopoly with capital-intensive, multi-year ramp cycles.

What Changes for Builders

For teams running production inference at scale, the memory squeeze is showing up in three places: lead times on H200 and MI300X-class systems stretching past two quarters, hyperscaler API pricing holding firm despite competitive pressure, and a re-emergence of efficiency-first model architectures — sparse MoE, KV-cache compression, and quantization techniques like Google's TurboQuant — being prioritized over raw parameter counts.

It also reshapes the AMD-versus-Nvidia debate. Both vendors are HBM-constrained at the wafer-back-end level, so accelerator choice increasingly reduces to which supplier got which memory allocation in which quarter.

The Read

A $6.5 billion thematic ETF reaching that scale in 36 days is itself a signal: capital is rotating away from the assumption that AI capex is bottlenecked by GPU compute, and toward the view that the binding constraint sits one layer deeper in the bill of materials. For enterprise buyers locking in 2027 capacity, the practical implication is that HBM allocation negotiations now matter as much as GPU SKU selection.

Learn AI for Free — FreeAcademy.ai

Take "AI for Business: Practical Implementation" — a free course with certificate to master the skills behind this story.

More in Industry

Google Ships Antigravity 2.0: A Standalone Agent Platform That Retires the Gemini CLI
Industry

Google Ships Antigravity 2.0: A Standalone Agent Platform That Retires the Gemini CLI

At I/O 2026, Google relaunched Antigravity as a standalone agent-orchestration platform with a CLI that replaces the Gemini CLI, an SDK, Managed Agents in the Gemini API, and an enterprise tier — all defaulting to Gemini 3.5 Flash.

10 min ago2 min read
Alibaba's Zhenwu M890 Claims 3x Nvidia's H20, Ships With Qwen 3.7-Max
Industry

Alibaba's Zhenwu M890 Claims 3x Nvidia's H20, Ships With Qwen 3.7-Max

Alibaba's chip unit T-Head unveiled the Zhenwu M890 AI accelerator, claiming 3x the agentic-inference performance of Nvidia's H20 and 144GB of HBM3, paired with the Qwen 3.7-Max model — a full domestic stack as US export controls tighten.

1 hours ago2 min read
Cohere Buys Reliant AI to Build 'North for Pharma' Sovereign Biopharma Agents
Industry

Cohere Buys Reliant AI to Build 'North for Pharma' Sovereign Biopharma Agents

Cohere has acquired Montréal- and Berlin-based biopharma startup Reliant AI, folding its automated research workbench into the North platform to launch 'North for Pharma' — its second acquisition in a month as it doubles down on sovereign, regulated-industry AI.

3 hours ago2 min read